Home
English
English
简体中文
Sign In
Help Desk
Journals
Advanced Search
BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Featured Articles
Journals
Submit a Manuscript
Articles Published Processes
Keyword:
Hepatitis B virus
1
Chronic hepatitis B and occult infection in chemotherapy patients - evaluation in oncology and hemato-oncology settings: The CHOICE study
3/11/2024 2:44:49 PM |
Browse: 29 |
Download: 30
2
Hepatitis B virus reactivation in patients treated with monoclonal antibodies
3/11/2024 2:44:49 PM |
Browse: 30 |
Download: 31
3
Antiviral treatment standards for hepatitis B: An urgent need for expansion
1/26/2024 7:56:29 AM |
Browse: 78 |
Download: 46
4
Dysregulated microRNAs as a biomarker for diagnosis and prognosis of hepatitis B virus-associated hepatocellular carcinoma
8/18/2023 10:08:22 AM |
Browse: 102 |
Download: 238
5
Association of vitamin D and polymorphisms of its receptor with antiviral therapy in pregnant women with hepatitis B
5/16/2023 7:16:46 AM |
Browse: 120 |
Download: 296
6
Locked nucleic acid real-time polymerase chain reaction method identifying two polymorphisms of hepatitis B virus genotype C2 infections, rt269L and rt269I
3/17/2023 6:20:53 AM |
Browse: 118 |
Download: 382
7
Immunological classification of hepatitis B virus-positive hepatocellular carcinoma by transcriptome analysis
12/23/2022 10:01:07 AM |
Browse: 173 |
Download: 430
8
Correlation between COVID-19 and hepatitis B: A systematic review
12/8/2022 9:04:30 AM |
Browse: 240 |
Download: 620
9
Heterogeneity of immune control in chronic hepatitis B virus infection: Clinical implications on immunity with interferon-α treatment and retreatment
10/28/2022 12:37:03 PM |
Browse: 213 |
Download: 318
10
Dynamic changes of estimated glomerular filtration rate are conversely related to triglyceride in non-overweight patients
10/27/2022 4:55:05 AM |
Browse: 174 |
Download: 446
11
VCAN, expressed highly in hepatitis B virus-induced hepatocellular carcinoma, is a potential biomarker for immune checkpoint inhibitors
10/14/2022 12:54:50 PM |
Browse: 215 |
Download: 787
12
Hepatitis B viral infection and role of alcohol
9/15/2022 1:37:25 PM |
Browse: 242 |
Download: 434
13
Gut microbiota of hepatitis B virus-infected patients in the immune-tolerant and immune-active phases and their implications in metabolite changes
9/15/2022 1:37:25 PM |
Browse: 228 |
Download: 543
14
Dissecting novel mechanisms of hepatitis B virus related hepatocellular carcinoma using meta-analysis of public data
9/9/2022 12:48:14 PM |
Browse: 273 |
Download: 733
15
Previous hepatitis B viral infection–underestimated cause of pancreatic cancer
8/31/2022 11:27:52 AM |
Browse: 278 |
Download: 926
16
Insights into induction of the immune response by the hepatitis B vaccine
8/16/2022 11:59:52 AM |
Browse: 267 |
Download: 485
17
Analysis of short-term prognostic factors of hepatitis B virus-related acute-on-chronic liver failure
8/1/2022 9:20:54 AM |
Browse: 204 |
Download: 415
18
Hepatitis B virus markers in hepatitis B surface antigen negative patients with pancreatic cancer: Two case reports
7/27/2022 1:17:38 PM |
Browse: 293 |
Download: 909
19
Gut microbiota alteration and modulation in hepatitis B virus-related fibrosis and complications: Molecular mechanisms and therapeutic inventions
7/27/2022 2:48:53 AM |
Browse: 249 |
Download: 477
20
Cautious optimism in anticipation of hepatitis B curative therapies
7/22/2022 7:22:19 AM |
Browse: 286 |
Download: 344
21
Hepatitis B and circadian rhythm of the liver
7/18/2022 9:47:46 AM |
Browse: 274 |
Download: 587
22
Epidemiological and clinical aspects of hepatitis B virus infection in Italy over the last 50 years
7/13/2022 7:30:59 AM |
Browse: 244 |
Download: 467
23
Difference in incidence of developing hepatocellular carcinoma between hepatitis B virus-and hepatitis C virus-infected patients
7/5/2022 8:40:56 AM |
Browse: 238 |
Download: 443
24
Long noncoding RNAs in hepatitis B virus replication and oncogenesis
7/4/2022 12:30:52 PM |
Browse: 280 |
Download: 425
25
Occult hepatitis B — the result of the host immune response interaction with different genomic expressions of the virus
6/9/2022 7:17:55 AM |
Browse: 247 |
Download: 580
26
Viral hepatitis and hepatocellular carcinoma: From molecular pathways to the role of clinical surveillance and antiviral treatment
6/2/2022 12:11:47 PM |
Browse: 390 |
Download: 1087
27
Role of hepatitis B virus in development of hepatocellular carcinoma: Focus on covalently closed circular DNA
5/24/2022 10:35:19 AM |
Browse: 261 |
Download: 512
28
Review on hepatitis B virus precore/core promoter mutations and their correlation with genotypes and liver disease severity
4/22/2022 10:52:23 AM |
Browse: 280 |
Download: 450
29
Innate and adaptive immune escape mechanisms of hepatitis B virus
3/3/2022 6:59:41 AM |
Browse: 358 |
Download: 590
30
Hepatitis B virus in cerebrospinal fluid of a patient with purulent bacterial meningitis detected by multiplex-PCR: A case report
2/11/2022 5:55:20 AM |
Browse: 252 |
Download: 378
31
Genotype E: The neglected genotype of hepatitis B virus
12/27/2021 5:24:00 AM |
Browse: 327 |
Download: 397
32
Unique situation of hepatocellular carcinoma in Egypt: A review of epidemiology and control measures
12/14/2021 11:58:12 PM |
Browse: 342 |
Download: 515
33
Effects of alcohol consumption on viral hepatitis B and C
11/22/2021 10:34:52 AM |
Browse: 322 |
Download: 546
34
Serum hepatitis B core-related antigen as a surrogate marker of hepatitis B e antigen seroconversion in chronic hepatitis B
10/27/2021 7:14:11 AM |
Browse: 356 |
Download: 910
35
Isolated hepatic tuberculosis associated with portal vein thrombosis and hepatitis B virus coinfection: A case report and review of literature
10/21/2021 8:44:05 AM |
Browse: 309 |
Download: 553
36
Hepatitis B virus persistent infection-related single nucleotide polymorphisms in HLA regions are associated with viral load in hepatoma families
9/29/2021 11:12:00 AM |
Browse: 379 |
Download: 668
37
Hepatitis B virus infection and hepatocellular carcinoma in sub-Saharan Africa: Implications for elimination of viral hepatitis by 2030?
9/23/2021 7:48:08 AM |
Browse: 461 |
Download: 759
38
Global prevalence of hepatitis B virus serological markers among healthcare workers: A systematic review and meta-analysis
9/22/2021 8:09:41 AM |
Browse: 360 |
Download: 481
39
Surveillance for hepatocellular carcinoma in chronic viral hepatitis: Is it time to personalize it?
9/3/2021 11:45:55 AM |
Browse: 430 |
Download: 591
40
Kidney transplant from donors with hepatitis B: A challenging treatment option
8/20/2021 9:33:19 AM |
Browse: 358 |
Download: 795
41
Naïve hepatitis B e antigen-negative chronic hepatitis B patients are at risk of carotid atherosclerosis: A prospective study
8/10/2021 6:48:43 AM |
Browse: 460 |
Download: 964
42
Hepatitis B virus infection modeling using multi-cellular organoids derived from human induced pluripotent stem cells
8/4/2021 7:56:20 AM |
Browse: 392 |
Download: 663
43
Prevention of hepatitis B reactivation in patients requiring chemotherapy and immunosuppressive therapy
7/21/2021 8:24:09 AM |
Browse: 407 |
Download: 1002
44
Viral hepatitis update: Progress and perspectives
7/12/2021 12:42:13 AM |
Browse: 442 |
Download: 649
45
Neoantigen vaccine: An emerging immunotherapy for hepatocellular carcinoma
7/10/2021 10:08:34 AM |
Browse: 377 |
Download: 637
46
Human immune repertoire in hepatitis B virus infection
7/6/2021 2:31:17 AM |
Browse: 240 |
Download: 486
47
Management of hepatitis B virus infection in patients with inflammatory bowel disease under immunosuppressive treatment
7/6/2021 2:31:17 AM |
Browse: 609 |
Download: 664
48
Advances in treatment and prevention of hepatitis B
7/1/2021 3:28:33 AM |
Browse: 377 |
Download: 628
49
Current impact of viral hepatitis on liver cancer development: The challenge remains
6/25/2021 9:46:23 AM |
Browse: 442 |
Download: 798
50
Hepatitis delta virus: From infection to new therapeutic strategies
6/25/2021 9:46:23 AM |
Browse: 335 |
Download: 633
Page 1 of 7 ( 341 items )
<<
1
2
3
4
5
6
7
>>
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345